Skip to content

Clinical trials

Completed Endocrine System Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Status: Completed Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20111
20142
20161
20171
20181
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ascendis Pharma Endocrinology Division A/S2
Eli Lilly and Company2
Celgene1
Groupe Hospitalier Pitie-Salpetriere1
Hoffmann-La Roche1
Institut National de la Santé Et de la Recherche Médicale, France1
Nantes University Hospital1
Pfizer1
Sumitomo Pharma America, Inc.1
University Hospital, Brest1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases13
Metabolic Diseases5
Glucose Metabolism Disorders4
Neoplasms4
Adenocarcinoma3
Diabetes Mellitus3
Diabetes Mellitus, Type 23
Digestive System Diseases3
Digestive System Neoplasms3
Endocrine Gland Neoplasms3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.